Differences in gene mutations according to gender among patients with colorectal cancer

Background: The incidence, site distribution, and mortality rates of patients with colorectal cancer differ according to gender. We investigated gene mutations in colorectal patients and wanted to examine gender-specific differences. Methods: A total of 1505 patients who underwent surgical intervention for colorectal cancer were recruited from March 2000 to January 2010 at Taipei Veterans' General Hospital and investigated for gene mutations in K-ras, N-ras, H-ras, BRAF, loss of 18q, APC, p53, SMAD4, TGF-beta, PIK3CA, PTEN, FBXW7, AKT1, and MSI. Results: There were significant differences between male and female patients in terms of tumor location (p < 0.0001) and pathological stage (p = 0.011). The female patients had significantly more gene mutations in BRAF (6.4 vs. 3.3%, OR 1.985, p = 0.006), TGF-beta (4.7 vs. 2.5%, OR 1.887, p = 0.027), and revealed a MSI-high status (14.0 vs. 83%, OR 1.800, p = 0. 001) than male patients. Male patients had significantly more gene mutations in N-ras (5.1 vs. 23%, OR 2227, p = 0. 012); however, the significance was maintained only for mutations in BRAF (OR 2.104, p = 0.038), M5I-high status (OR 2. 003 p = 0.001), and N-ras (OR 3.000, p = 0.010) after the groups were divided by tumor site. Conclusion: Gene mutations in BRAF, MSI-high status, and N-ras differ according to gender among patients with colorectal cancer.